KRAS and non-small cell lung carcinoma: Although poor survival in NSCLC patients with Twist1 overexpression could be explained by its function as an important EMT regulator, this observation could also be related to other important molecular changes in NSCLC, such as epidermal growth factor receptor (EGFR), K-ras, and/or p53 mutations.